You just read:

The Zacks Analyst Blog Highlights:Intercept Pharmaceuticals, AT&T, Verizon Communications, Sprint and T-Mobile US

News provided by

Zacks Investment Research, Inc.

Jan 13, 2014, 09:30 ET